Global Leading Market Research Publisher QYResearch announces the release of its latest report “Disposable Coaxial Biopsy Needle – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Disposable Coaxial Biopsy Needle market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for Disposable Coaxial Biopsy Needle was estimated to be worth US$ 33.44 million in 2025 and is projected to reach US$ 42.42 million, growing at a CAGR of 3.5% from 2026 to 2032.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5511769/disposable-coaxial-biopsy-needle
Disposable Coaxial Biopsy Needle Market Overview: Advancing Precision Diagnostics in Minimally Invasive Medical Procedures
The Disposable Coaxial Biopsy Needle market, a critical segment within the global minimally invasive surgical devices and medical diagnostic consumables industry, is witnessing steady expansion driven by rising demand for accurate, safe, and efficient tissue sampling technologies. These devices are widely used in image-guided biopsy procedures, enabling clinicians to obtain high-quality tissue samples with reduced patient trauma and improved diagnostic accuracy.
Between 2021 and 2025, market growth has been supported by increasing cancer screening rates, expansion of interventional radiology procedures, and rising adoption of image-guided diagnostic technologies such as CT and ultrasound-guided biopsies. However, the market still faces challenges including procedural cost sensitivity, reimbursement variability across regions, and the need for highly skilled medical professionals to ensure accurate needle placement.
From 2026 to 2032, demand is expected to grow steadily due to expanding oncology diagnostics, increasing preference for minimally invasive procedures, and continuous improvements in biopsy needle design and imaging integration.
Core keywords defining this market include:
- Minimally invasive biopsy devices
- Coaxial biopsy needle systems
- Image-guided diagnostic consumables
- Interventional radiology instruments
- Disposable medical puncture devices
Market Size, Structure, and Competitive Landscape
The global Disposable Coaxial Biopsy Needle market was valued at US$ 33.44 million in 2025 and is projected to reach US$ 42.42 million by 2032, growing at a CAGR of 3.5% during the forecast period. Although relatively niche in size compared to broader medical device markets, it plays a crucial role in cancer diagnostics and tissue pathology workflows.
The market is moderately consolidated, with a small number of leading global manufacturers accounting for a significant share of production capacity.
Key manufacturers include:
BD
Merit Medical Systems
Argon Medical Devices
TSK Laboratory
IZI Medical
Medax
AprioMed
GEOTEK
Mammotome
MÖLLER Medical
TUOREN
Curaway Medical
INRAD
Biopsybell
Zamar Care
Vigeo
MDL Srl
Mermaid Medical
Notably, the top six manufacturers collectively account for more than 50% of global market share, with BD recognized as the leading global supplier. Over the past six months, manufacturers have increasingly focused on enhancing needle tip sharpness, imaging visibility, and procedural stability, improving puncture efficiency and reducing tissue trauma during biopsy procedures.
Market Segmentation Analysis
By Type: Gauge-Based Product Differentiation
13G Biopsy Needles
Primarily used for larger tissue sampling requirements in deep tissue diagnostics and certain oncology applications.
15G Biopsy Needles
Balanced design used across general interventional biopsy procedures.
17G Biopsy Needles
Currently one of the most widely used segments, accounting for a significant share of the market due to its balance of precision and sample adequacy.
19G Biopsy Needles
This segment is experiencing faster relative growth due to improved minimally invasive procedural demand and reduced patient trauma requirements.
Others
Includes specialized and custom-designed biopsy needle configurations for niche clinical applications.
From a clinical engineering standpoint, advancements in needle wall thickness optimization and cutting-edge geometry design are improving tissue capture efficiency while reducing insertion resistance.
By Application: Clinical End-User Distribution
Hospitals
The dominant application segment, accounting for over 70% of total market demand. Hospitals rely heavily on disposable coaxial biopsy needles for oncology diagnostics, interventional radiology, and surgical pathology.
Clinics
This segment continues to expand as outpatient diagnostic services become more widely available and imaging-guided procedures shift toward decentralized healthcare delivery models.
Others
Includes research institutions and specialized diagnostic centers.
Regional Analysis and Production Landscape
Global production of disposable coaxial biopsy needles is primarily concentrated in North America, Europe, China, and Japan, together accounting for more than 80% of total production. Among these, North America remains the largest production region, contributing over 60% of global output.
Recent developments in the last six months indicate increasing investment in automated manufacturing processes for precision medical needles, particularly in Europe and North America, aimed at improving consistency in cutting-edge manufacturing tolerances.
Industry Dynamics and Recent Developments (Last 6 Months Insight)
- Rising global cancer screening rates
Increased early detection programs are driving demand for high-precision biopsy tools. - Advancements in imaging-guided biopsy systems
Integration with CT, MRI, and ultrasound imaging enhances procedural accuracy. - Material and design innovation in needle manufacturing
Manufacturers are improving stainless steel alloys and coating technologies to reduce friction and improve penetration efficiency. - Shift toward outpatient diagnostic procedures
Healthcare systems are increasingly favoring minimally invasive, same-day diagnostic workflows.
Technology Trends and Engineering Challenges
Despite steady growth, the Disposable Coaxial Biopsy Needle market faces several technical and operational challenges:
- Precision targeting in deep tissue biopsies
Accurate positioning remains dependent on imaging quality and physician expertise. - Tissue sample integrity preservation
Ensuring high-quality samples without deformation is a key engineering challenge. - Cost constraints in emerging markets
Disposable device usage can strain healthcare budgets in developing regions.
Emerging innovation trends include:
- Enhanced imaging-compatible needle coatings
- Ultra-sharp multi-bevel tip designs
- Ergonomic coaxial deployment systems
- AI-assisted biopsy guidance technologies
Industry Segmentation Insight: Hospital vs Outpatient Diagnostic Shift
A key structural trend shaping the market is the divergence between hospital-based diagnostic systems and clinic-based outpatient services:
- Hospitals dominate due to complex oncology diagnostics and advanced imaging infrastructure.
- Clinics are expanding rapidly as healthcare systems shift toward decentralized, cost-efficient diagnostic care models.
This dual structure is reshaping product demand, with increasing emphasis on portability, ease of use, and procedural efficiency.
Case Study: CT-Guided Liver Biopsy Optimization
Recent clinical applications (2025–2026) demonstrate that advanced coaxial biopsy needle systems significantly improve tissue sample adequacy in CT-guided liver biopsies while reducing complication rates. Improved imaging markers on needle shafts have also enhanced procedural accuracy, particularly in deep-seated tumor sampling.
Market Outlook and Strategic Direction
From 2026 to 2032, the Disposable Coaxial Biopsy Needle market is expected to evolve toward:
- Continued innovation in precision needle engineering
- Expansion of image-guided minimally invasive diagnostics
- Increasing adoption in outpatient healthcare settings
- Enhanced integration with advanced imaging technologies
The market will remain technology-driven, with incremental improvements in safety, accuracy, and patient comfort shaping long-term demand.
Conclusion
The Disposable Coaxial Biopsy Needle market represents a vital segment of modern diagnostic medicine. Driven by rising oncology cases, technological advancements in interventional radiology, and the global shift toward minimally invasive procedures, the market is expected to maintain steady and sustainable growth through 2032.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
